Dr. John Ringman, Associate Clinical Professor of Neurology, David Geffen School of Medicine at UCLA, and Associate Clinical Director, Mary S. Easton Center for Alzheimer's Disease Research at UCLA was featured in Feb. 1 Dr. Bruce Hensel's medical report on NBCLA Channel 4 News. Dr. Ringman talked about how rarely, Alzheimer's disease is inherited in a highly genetic fashion in which changes in specific genes have been identified that essentially guarantee the onset of the disease at a relatively young age. Investigators are now using this knowledge to administer promising medications to prevent the disease to persons carrying such genetic alterations to potentially prevent them from manifesting symptoms of the disease. Such trials are being initiated at UCLA and other sites within the next 6 months.
Dr. David Teplow, Professor of Neurology, was featured in Jan. 23 Examiner.com and Scrupsreport.com, articles about his research that, for the first time, isolated a unique hairpin-like segment of a toxic protein associated with Alzheimer's disease, that may be a precise target for drug delivery that would slow or stop the disease.
Dr. Joshua Grill, Assistant Professor of Neurology and Director of Education for the Mary S. Easton Center for Alzheimer's Disease Research at UCLA, was featured in several outlets regarding his research showing that the outcome of any Alzheimer's clinical trial can be influenced by who the patient's study partner is, whether it's a spouse, adult child, or "other." Coverage included Dec. 19 in the Examiner.com and Science Daily; Dec. 20 in MedPage Today; and Dec. 21 in NewsMedical.net and Labmate Online.
Dr. John Ringman, Associate Clinical Professor of Neurology, David Geffen School of Medicine at UCLA, and Associate Clinical Director, Mary S. Easton Center for Alzheimer's Disease Research at UCLA was quoted Dec. 13 in a LA Times article about a possible therapeutic drug, which will begin the five-year clinical trial next Spring in Yarumal, Colombia. The name of this drug trial is called Alzheimer's Prevention Initiative. Dr. Ringman and his group will also be enrolling subjects in this study at the Easton Center at UCLA.
Dr. David B. Teplow, Professor of Neurology and Interim Director of the Mary S. Easton Center for Alzheimer's Disease Research at UCLA, was quoted Nov. 28 in a Chicago Tribune story about a study that used a human gene in mice to more accurately measure the damage caused by Alzheimer's disease.